Inhibitory smad7: Emerging roles in health and disease

Current Molecular Pharmacology

Volumn 4, Issue 2, 2011, Pages 141-153

  Briones Orta, Marco A ^a   Tecalco Cruz, Angeles C ^a   Sosa Garrocho, Marcela ^a   Caligaris, Cassandre ^a   Macias Silva, Marina ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Alk5; Cancer; Fibrosis; Smad; Smad7; TGF

Indexed keywords

ASIATICOSIDE; ENALAPRIL; MESSENGER RNA; SMAD7 PROTEIN; TETRAMETHYLPYRAZINE; TRANSFORMING GROWTH FACTOR BETA;

ACETYLATION; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL ADHESION; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM DISEASE; COLITIS; DEACETYLATION; FIBROSIS; GENE EXPRESSION; HUMAN; LIVER FIBROSIS; LUNG FIBROSIS; NEGATIVE FEEDBACK; NEOPLASM; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; UBIQUITINATION; UPREGULATION;

EID: 79953791902     PISSN: 18744672     EISSN: 18744702     Source Type: Journal    
DOI: 10.2174/1874467211104020141     Document Type: Article

References (111)

1. Kang, J.S.; Liu, C; Derynck, R. New regulatory mechanisms of TGF-beta receptor function. Trends Cell Biol, 2009, 79(8), 385-394.
2. Massagué, J.; Wotton, D. Transcriptional control by the TGF-β/Smad signaling system. EMBOJ., 2000, 79(8), 1745-1754.
3. Attisant, L.; Lee-Hoeflich, S.T. The Smads. Genome Biol, 2001, 2(8), 30100-30108.
4. Feng, X.H.; Derynck, R. Specificity and versatility in TGF-beta signaling through Smads. Annu. Rev. Cell Dev. Biol., 2005, 21, 659-693.
5. Massagué, J.; Seoane, J.; Wotton, D. Smad transcription factors. Genes Dev., 2005, 79(23), 2783-2810.
6. Afrakhte, M.; Moren, A.; Jossan, S.; Itoh, S.; Sampath, K.; Westermark, B.; Heldin, C.H.; Heldin, N.E.; ten Dijke P. Induction of inhibitory Smad6 and Smad7 mRNA by TGF-beta family mem-bers. Biochem. Biophys. Res. Commun., 1998, 249(2), 505-511.
7. Denissova, N.G.; Pouponnot, C; Long, J.: He, D; Liu, F. Transforming growth factor beta-inducible independent binding of SMAD to the Smad7 promoter. Proc. Nat. Acad. Sei. USA, 2000, 97(12), 6397-6402.
8. Nakao, A.; Afrakhte, M.; Morén, A.; Nakayama, T.; Christian, J.L.; Heuchel, R.; Itoh, S.; Kawabata, M.; Heldin, N.E.; Heldin, C.H.; ten Dijke, P. Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signaling. Nature, 1997, 389(6651), 631-635.
9. Nagarajan, R.P.; Zhang, J.; Li, W.; Chen, Y. Regulation of Smad7 promoter by direct association with Smad3 and Smad4. J. Biol. Chem., 1999, 274(47), 33412-33418.
10. Benchabane, H.; Wrana, J.L. GATA- and Smad 1-dependent enhancers in the Smad7 gene differentially interpret bone morphoge-netic protein concentrations. Mol. Cell. Biol, 2003, 25(18), 6646-6661.
11. Denissova, N.G.; Liu, F. Repression of endogenous Smad7 by Ski. J. Biol. Chem., 2004, 279(27), 28143-28148.
12. Jungert, K.; Buck, A.; Buchholz, M.; Wagner, M.; Adler, G.; Gress, T.M.; Ellenrieder, V. Smad-Spl complexes mediate TGFbeta-induced early transcription of oncogenic Smad7 in pancreatic cancer cells. Carcinogenesis, 2006, 27(12), 2392-2401.
13. Ku, M.; Howard, S.; Ni, W.; Lagna, G.; Hâta, A. OAZ regulates bone morphogenetic protein signaling through Smadô activation. J Biol. Chem., 2006, 281, 5277-5287.
14. Topper, J.N.; Cai, J.; Qiu, Y.; Anderson, K.R.; Xu, Y.Y.; Deeds, J.D.; Feeley, R.; Gimeno, CI; Woolf, E.A.; Tayber, O.; Mays, G.G.; Sampson, B.A.; Schoen, F.J.; Gimbrone, M.A. Jr.; Falb, D. Vascular MADs: two novel MAD-related genes selectively induc-ible by flow in human vascular endothelium. Proc. Nati. Acad. Sei. USA, 1997, 94(17), 9314-9319.
15. Stopa, M.; Benes, V.; Ansorge, W.; Gressner, AM.; Dooley, S. Genomic locus and promoter region of rat Smad7, an important antagonist of TGF beta signaling. Mamm. Genome, 2000, 11(2), 169-176.
16. Casellas, R.; Brivanlou, A.H. Xenopus Smad7 inhibits both the activin and BMP pathways and acts as a neural inducer. Dev. Biol, 1998,198, 1-12.
17. Hayashi, H.; Abdullah, S.; Qiu, Y.; Cai, J.; Xu, Y.Y.; Grinnell, BW.; Richardson, MA.; Topper, JN.; Gimbrone, MA. Jr.; Wrana, JL.; Falb, D. The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling. Cell, 1997, 89(1), 1165-1173.
18. Macias-Silva, M.; Abdullah, S.; Hoodless, P.A, Pirone, R.; Atti-sano, L.; Wrana, J.L. MADR2 is a substrate of the TGFbeta receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell, 1996, 57(7), 1215-1224.
19. Chong, P.A.; Lin, H.; Wrana, J.L.; Forman-Kay, J.D. An expanded WW domain recognition motif revealed by the interaction between Smad7 and the E3 ubiquitin ligase Smurf2. J. Biol. Chem., 2006, 257(25), 17069-17075.
20. Wrana, J.L.; Attisano, L. The Smad pathway. Cytokine Growth Factor Rev., 2000, 77(1-2), 5-13.
21. Briones-Orta, M.A.; Sosa-Garrocho, M.; Moreno-Alvarez, P.; Fonseca-Sánchez, M.A.; Macias-Silva, M. SnoN co-repressor binds and represses smad7 gene promoter. Biochem. Biophys. Res. Commun., 2006, 341(3), 889-894.
22. Davis, B.N.; Hilyard, A.C.; Lagna, G.; Hata, A. SMAD proteins control DROSHA-mediated microRNA maturation. Nature, 2008, 454(7200), 56-61.
23. Liu, G.; Friggeri, A.; Yang, Y.; Milosevic, J.; Ding, Q.; Than-nickal, V.J.; Kaminski, N.; Abraham, E. miR-21 mediates fibro-genic activation of pulmonary fibroblasts and lung fibrosis. J. Exp. Med, 2010, 207(8), 1589-97.
24. Shi, Y.; Massagué, J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell, 2003, 775(6), 685-700.
25. Schmierer, B.; Hill, CS. TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility. Nat. Rev. Mol. Cell. Biol, 2007, 5(12), 970-982.
26. Souchelnytskyi, S.; Nakayama, T.; Nakao, A.; Morén, A.; Heldin, CH.; Christian, JL.; ten Dijke, P. Physical and functional interaction of murine and Xenopus Smad7 with bone morphogenetic protein receptors and transforming growth factor-beta receptors. J. Biol. Chem., 1998, 275(39), 25364-25370.
27. Kavsak, P.; Rasmussen, R.K.; Causing, C.G.; Bonni, S.; Zhu, H.; Thomsen, G.H.; Wrana, J.L. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Mol. Cell, 2000, 6(6), 1365-1375.
28. Kuratomi, G.; Komuro, A.; Goto, K.; Shinozaki, M.; Miyazawa, K.; Miyazono, K.; Imamura, T. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor. Biochem. J., 2005, 386(Pt 3), 461-470.
29. Ebisawa, T.; Fukuchi, M.; Murakami, G.; Chiba, T.; Tanaka, K.; Imamura, T.; Miyazono, K. Smurfl interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation. J. Biol. Chem., 2001, 276(16), 12477-12480.
30. Murakami, G.; Watabe, T.; Takaoka, K.; Miyazono, K.; Imamura T. Cooperative inhibition of bone morphogenetic protein signaling by Smurfl and inhibitory Smads. Mol. Biol. Cell, 2003, 14(1), 2809-2817.
31. Imamura, T.; Takase, M.; Nishihara, A.; Oeda, E.; Hanai, J.; Kawabata, M.; Miyazono, K. Smad6 inhibits signalling by the TGFbeta superfamily. Nature, 1997, 559(6651), 622-626.
32. Shi, W.; Sun, C; He, B.; Xiong, W.; Shi, X.; Yao, D.; Cao, X. GADD34-PPlc recruited by Smad7 dephosphorylates TGFbeta type I receptor. J. Cell. Biol, 2004,164(2), 291-300.
33. Itoh, S.; Landström, M.; Hermansson, A.; Itoh, F.; Heldin, CH.; Heldin, NE.; ten Dijke, P. Transforming growth factor betal induces nuclear export of inhibitory Smad7. J. Biol. Chem., 1998, 275(44), 29195-29201.
34. Tajima, Y.; Goto, K.; Yoshida, M.; Shinomiya, K.; Sekimoto, T.; Yoneda, Y.; Miyazono, K.; Imamura, T. Chromosomal region maintenance 1 (CRMIndependent nuclear export of Smad ubiquitin regulatory factor 1 (Smurfl) is essential for negative regulation of transforming growth factor-beta signaling by Smad7. J. Biol. Chem., 2003, 275(12), 10716-10721.
35. Kim, B.C.; Lee, H.J.; Park, S.H.; Lee, S.R.; Karpova, T.S.; McNally, J.G.; Felici, A.; Lee, D.K.; Kim, S.J. Jabl/CSN5, a component of the COP9 signalosome, regulates transforming growth factor beta signaling by binding to Smad7 and promoting its degradation. Mol. Cell. Biol, 2004, 24(6), 2251-2262.
36. Komuro, A.; Imamura, T.; Saitoh, M.; Yoshida, Y.; Yamori, T.; Miyazono, K.; Miyazawa, K. Negative regulation of transforming growth factor-beta (TGF-beta) signaling by WW domain-containing protein 1 (WWP1). Oncogene, 2004, 25(41), 6914-6923.
37. Zhang, S.; Fei, T.; Zhang, L.; Zhang, R.; Chen, F.; Ning, Y.; Han, Y.; Feng, XH.; Meng, A.; Chen, YG. Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formation. Mol Cell. Biol, 2007, 27(12), 4488-4499.
38. Shi, X.; Chen, F.; Yu, J.; Xu, Y.; Zhang, S.; Chen, Y.G.; Fang, X. Study of interaction between Smad7 and DNA by single-molecule force spectroscopy. Biochem. Biophys. Res. Commun., 2008, 577(4), 1284-1287.
39. Hata, A.; Lagna, G.; Massagué, J.; Hemmati-Brivanlou, A. Smad6 inhibits BMP/Smadl signaling by specifically competing with the Smad4 tumor suppressor. Genes Dev., 1998, 72(2), 186-97.
40. Morén, A.; Imamura, T.; Miyazono, K.; Heldin, C.H.; Moustakas, A. Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases. J. Biol. Chem., 2005, 250(23), 22115-22123.
41. Pulaski, L.; Landstrom, M.; Heldin, C.H.; Souchelnytskyi, S. Phosphorylation of Smad7 at Ser-249 does not interfere with its inhibitory role in transforming growth factor-beta-dependent signaling but affects Smad7-dependent transcriptional activation. J. Biol. Chem., 2001, 276(17), 14344-14349.
42. Ulloa, L.; Doody, J; Massague, J. Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway. Nature, 1999, 397, 710-713.
43. Bitzer, M.; von Gersdorff, G.; Liang, D.; Dominguez-Rosales, A.; Beg, A. A.; Rojkind, M.; Bottinger, E. P. A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelA. Genes Dev., 2000,14, 187-197.
44. Quan, T.; He, T.; Voorhees, J.J.; Fisher, G.J. Ultraviolet irradiation blocks cellular responses to transforming growth factor-beta by down-regulating its type-II receptor and inducing Smad7. J. Biol. Chem., 2001, 276, 26349-26356.
45. Patil, S.; Wildey, G.M.; Brown, T.L.; Choy, L.; Derynck, R.; Howe, P.H. Smad7 is induced by CD40 and protects WEHI 231 B-lymphocytes from transforming growth factor-beta-induced growth inhibition and apoptosis. J. Biol. Chem., 2000, 275, 38363-38370.
46. Zwijsen, A.; van Rooijen, M.A.; Goumans, M.J.; Dewulf, N.; Bosman, E.A.; ten Dijke, P.; Mummery, C.I.; Huylebroeck, D. Expression of the inhibitory Smad7 in early mouse development and upregulation during embryonic vasculogenesis. Dev. Dyn., 2000, 218, 663-670.
47. Tsunobuchi, H.; Ishisaki, A.; Imamura, T. Expressions of inhibitory Smads, Smad6 and Smad7, are differentially regulated by TPA in human lung fibroblast cells. Biochem. Biophys. Res. Commun., 2004, 316, 712-719.
48. Seth, R.B.; Chen, Z.J. Smads keep TABs on inflammation. Nat. Immunol, 2007, 5(5), 477-478.
49. Hong, S.; Lee, C; Kim, S.J. Smad7 sensitizes tumor necrosis factor induced apoptosis through the inhibition of antiapoptotic gene expression by suppressing activation of the nuclear factor-kappaB pathway. Cancer Res., 2007, 67(19), 9577-9583.
50. Lee, Y.S.; Kim, J.H.; Kim, S.T.; Kwon, J.Y.; Hong, S.; Kim, S.J.; Park, S.H. Smad7 and Smad6 bind to discrete regions of Pellino-1 via their MH2 domains to mediate TGF-betal-induced negative regulation of IL-1R/TLR signalling. Biochem. Biophys. Res. Commun., 2010, 393 (4), 836-843.
51. Hoffmann, A.; Preobrazhenska, O.; Wodarczyk, C; Medler, Y.; Winkel, A.; Shahab, S.; Huylebroeck, D.; Gross, G.; Verschueren, K. Transforming growth factor-beta-activated kinase-1 (TAK1), a MAP3K, interacts with Smad proteins and interferes with os-teogenesis in murine mesenchymal progenitors. J. Biol. Chem., 2005, 280(29), 27271-27283.
52. Hong, S.; Lim, S.; Li, AG.; Lee, C; Lee, YS.; Lee, EK.; Park, SH.; Wang, XI; Kim, SJ. Smad7 binds to the adaptors TAB2 and TAB3 to block recruitment of the kinase TAK1 to the adaptor TRAF2. Nat. Immunol, 2007, 5(5), 504-513.
53. Hong, S.; Lee, C; Kim, SJ. Smad7 sensitizes tumor necrosis factor induced apoptosis through the inhibition of antiapoptotic gene expression by suppressing activation of the nuclear factor-kappaB pathway. Cancer Res., 2007, 67(19), 9577-9583.
54. Han, G.; Li, AG.; Liang, YY.; Owens, P.; He, W.; Lu, S.; Yoshi-matsu, Y.; Wang, D.; Ten Dijke, P.; Lin, X.; Wang, XJ. Smad7-induced beta-catenin degradation alters epidermal appendage development. Dev. Cell, 2006, 77(3), 301-312.
55. Millar, S.E. Smad7: licensed to kill beta-catenin. Dev. Cell. 2006, 77(3), 274-276.
56. Gronroos, E.; Hellman, U.; Heldin, CH.; Ericsson, J. Control of Smad7 stability by competition between acetylation and ubiquitina uon. Mol. Cell, 2002, 70(3), 483-493.
57. Kume, S.; Haneda, M.; Kanasaki, K.; Sugimoto, T.; Araki, S.; Isshiki, K.; Isono, M.; Uzu, T.; Guarente, L.; Kashiwagi, A.; Koya, D. SIRT1 inhibits transforming growth factor beta-induced apoptosis in glomerular mesangial cells via Smad7 deacetylation. J. Biol. Chem., 2007, 252(1), 151-158.
58. Simonsson, M.; Heldin, CH.; Ericsson, J.; Grönroos, E. The balance between acetylation and deacetylation controls Smad7 stability. J. Biol. Chem., 2005, 250(23), 21797-21803.
59. Liu, W.; Rui, H.; Wang, J.; Lin, S.; He, Y.; Chen, M.; Li, Q.; Ye, Z.; Zhang, S.; Chan, S.C.; Chen, Y.G.; Han, J.; Lin, S.C. Axin is a scaffold protein in TGF-beta signaling that promotes degradation of Smad7 by Arkadia. EMBOJ., 2006, 25(8), 1646-1658.
60. Koinuma, D.; Shinozaki, M.; Komuro, A.; Goto, K.; Saitoh, M.; Hanyu, A.; Ebina, M.; Nukiwa, T.; Miyazawa, K.; Imamura, T.; Miyazono, K. Arkadia amplifies TGF-beta superfamily signalling through degradation of Smad7. EMBOJ., 2003, 22(24), 6458-6470.
61. Ibarrola, N.; Kratchmarova, I.; Nakajima, D.; Schiemann, WP.; Moustakas, A.; Pandey, A.; Mann, M. Cloning of a novel signaling molecule, AMSH-2, that potentiates transforming growth factor beta signaling. BMC Cell Biol, 2004, 5, 2.
62. Zhang, S.; Ekman, M.; Thakur, N.; Bu, S.; Davoodpour, P.; Grimsby, S.; Tagami, S.; Heldin, C.H.; Landstrom, M. TGFbetal-induced activation of ATM and p53 mediates apoptosis in a Smad7-dependent manner. Cell Cycle, 2006, 5(23), 2787-2795.
63. Imoto, S.; Sugiyama, K.; Muromoto, R.; Sato, N.; Yamamoto, T.; Matsuda, T. Regulation of transforming growth factor-beta signaling by protein inhibitor of activated STAT, PIASy through Smad3. J. Biol. Chem., 2003, 275(36), 34253-34258.
64. Yamaguchi, T.; Kurisaki, A.; Yamakawa, N.; Minakuchi, K.; Su-gino, H. FKBP12 functions as an adaptor of the Smad7-Smurfl complex on activin type I receptor. J. Mol. Endocrino!, 2006, 36(3), 569-579.
65. Seong, H.A.; Jung, H.; Kim, K.T.; Ha, H. 3-phosphoinositide-dependent PDK1 negatively regulates transforming growth factor-beta-induced signaling in a kinase-dependent manner through physical interaction with Smad proteins. J. Biol. Chem., 2007, 252(16), 12272-12289.
66. Yoshida, Y.; von Bubnoff, A.; Ikematsu, N.; Blitz, I.L.; Tsuzuku, J.K.; Yoshida, E.H.; Umemori, H.; Miyazono, K.; Yamamoto, T.; Cho, K.W. Tob proteins enhance inhibitory Smad-receptor interactions to repress BMP signaling. Mech. Dev, 2003, 720(5), 629-637.
67. Torregroza, I.; Evans, T. Tidl is a Smad-binding protein that can modulate Smad7 activity in developing embryos. Biochem. J., 2006, 393(Ptl), 311-320.
68. Ferrigno, O.; Lallemand, F.; Verrecchia, F.; L'Hoste, S.; Camonis, J.; Atfi, A.; Mauviel, A. Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-beta/Smad signaling. Oncogene, 2002, 27(32), 4879-4884.
69. Datta, P.K.; Moses, H.L. STRAP and Smad7 synergize in the inhibition of transforming growth factor beta signaling. Mol. Cell. Biol., 2000, 20(9), 3157-3167.
70. Li, R.; Rosendahl, A.; Brodin, G.; Cheng, A.M.; Ahgren, A.; Sund-quist, C; Kulkarni, S.; Pawson, T.; Heldin, C.H.; Heuchel, R.L. Deletion of exon I of SMAD7 in mice results in altered B cell responses. J. Immunol, 2006, 176(11), 6777-6784.
71. Chen, Q.; Chen, H.; Zheng, D.; Kuang, C; Fang, H.; Zou, B.; Zhu, W.; Bu, G.; Jin, T.; Wang, Z.; Zhang, X.; Chen, J.; Field, L.J.; Ru-bart, M.; Shou, W.; Chen, Y. Smad7 Is required for the development and function of the heart. J. Biol. Chem., 2009, 284(1), 292-300.
72. He, W.; Li, AG.; Wang, D.; Han, S.; Zheng, B.; Goumans, M.J.; Ten Dijke, P.; Wang, X.J. Overexpression of Smad7 results in severe pathological alterations in multiple epithelial tissues. EMBO J.,2002, 27(11), 2580-2590.
73. He, J.; Sun, X.; Qian, K.; Liu, X.; Wang, Z.; Chen, Y. Protection of cerulein-induced pancreatic fibrosis by pancreas-specific expression of Smad7. Biochim. Biophys. Acta, 2009, 7 792, 56-60.
74. Liu, X.; Chen, Q.; Kuang, C; Zhang, M.; Ruan, Y.; Xu, Z.C.; Wang, Z.; Chen, Y. A. 4.3kb Smad7 promoter is able to specify gene expression during mouse development. Biochim. Biophys. Acta, 2007, 1769(2), 149-152.
75. Kollias, H.D.; Perry, R.L.; Miyaké, T.; Aziz, A.; McDermott, J.C. Smad7 promotes and enhances skeletal muscle differentiation. Mol. Cell. Biol, 2006, 26(16), 6248-6260.
76. Miyaké, T.; Alii, N.S.; McDermott, J.C. Nuclear function of Smad7 promotes myogenesis.Mol. CellBiol, 2010, 30(3), 722-735.
77. Branton, M.H.; Kopp, J.B. TGF-beta and fibrosis. Microbes Infect., 1999, 7(15), 1349-1365.
78. Detlefsen, S.; Sipos, B.; Feyerabend, B.; Klöppel, G. Fibrogenesis in alcoholic chronic pancreatitis: the role of tissue necrosis, macrophages, myofibroblasts and cytokines. Mod. Pathol, 2006, 79(8), 1019-1026.
79. Haber, P.S.; Keogh, G.W.; Apte, M.V.; Moran, C.S.; Stewart, N.L.; Crawford, D.H.; Piróla, R.C.; McCaughan, G.W.; Ramm, G.A.; Wilson, J.S. Activation of pancreatic stellate cells in human and experimental pancreatic fibrosis. Am. J. Pathol, 1999, 755(4), 1087-1095.
80. Dooley, S.; Hamzavi, J.; Breitkopf, K.; Wiercinska, E.; Said, H.M.; Lorenzen, J. Ten Dijke, P.; Gressner, A.M. Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroen-terology, 2003, 725(1), 178-191.
81. Seyhan, H.; Hamzavi, J.; Wiercinska, E.; Gressner, A.M.; Mertens, P.R.; Kopp, J.; Horch, R.E.; Breitkopf, K.; Dooley, S. Liver fibro-genesis due to cholestasis is associated with increased Smad7 expression and Smad3 signaling. J. Cell. Mol. Med., 2006, 10(4), 922-932.
82. Chung, A.C.; Huang, X.R.; Zhou, L.; Heuchel, R.; Lai, K.N.; Lan, H. Y. Disruption of the Smad7 gene promotes renal fibrosis and inflammation in unilateral ureteral obstruction (UUO) in mice. Neph-rol. Dial. Transplant, 2009, 24(5), 1443-1454.
83. Ning, W.; Tao, L.; Liu, C; Sun, J.; Xiao, Y.; Hu, J.; Chen, J.; Zheng, X.; Wang, W. Effect of enalapril: on the expression of TGF-betal, p-Smad2/3 and Smad7 in renal interstitial fibrosis in rats. Zhong Nan Da Xue Xue Bao YiXueBan, 2009, 34(1), 27-34.
84. Lu, M.; Zhou, J.; Wang, F.; Liu, Y.; Zhang, Y. Effect of tetramethylpyrazine on expression of Smad7 and SnoN in rats with UUO. Zhongguo Zhong Yao Za Zhi, 2009. 34(1), 84-88.
85. Lan, H.Y.; Mu, W.; Tomita, N.; Huang, X.R.; Li, J.H.; Zhu, HJ.; Morishita, R.; Johnson, R.J. Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model. J. Am. Soc. Nephrol, 2003,14(6), 1535-1548.
86. Wang, B.; Hao, J.; Jones, S.C.; Yee, M.S.; Roth, J.C.; Dixon, I.M. Decreased Smad7 expression contributes to cardiac fibrosis in the infarcted rat heart. Am. J. Physiol. Heart. Circ. Physio!, 2002, 282(5), H1685-1696.
87. Nakao, A.; Fujii, M.; Matsumura, R.; Kumano, K.; Saito, Y.; Mi-yazono, K.; Iwamoto, I. Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. J. Clin. Invest, 1999,104(1), 5-11.
88. Kreuter, A.; Hyun, J.; Skrygan, M.; Sommer, A.; Tomi, N.S.; Breuckmann, F.; Altmeyer, P.; Gambichler, T. Ultraviolet Al phototherapy decreases inhibitory SMAD7 gene expression in localized scleroderma. Arch. Dermatol. Res., 2006, 298(6), 265-272.
89. Miyazono, K. Regulation of TGF-β family signaling by inhibitory smads, The TGF-β family; Derynck, R.; Miyazono, K., Ed.; Cold Spring Harbor Laboratory Press: NY, 2008, pp. 363-387.
90. Dowdy, S.C.; Mariani, A.; Reinholz, M.M.; Keeney, G.L.; Spels-berg, T.C.; Podratz, K.C.; Janknecht, R. Overexpression of the TGF-beta antagonist Smad7 in endometrial cancer. Gynecol. Oncol, 2005, 96(2), 368-373
91. Cerutti, J.M.; Ebina, K.N.; Matsuo, S.E.; Martins, L.; Maciel, R.M.; Kimura, E.T. Expression of Smad4 and Smad7 in human thyroid follicular carcinoma cell lines. J. Endocrino! Invest., 2003, 26(6), 516-521.
92. Javelaud, D.; Delmas, V.; Möller, M.; Sextius, P.; André, J.; Me-nashi, S.; Larue, L.; Mauviel, A. Stable overexpression of Smad7 in human melanoma cells inhibits their tumorigenicity in vitro and in vivo. Oncogene, 2005, 24(51), 7624-7629.
93. Boyer, A.N.; Korc, M. Smad7 abrogates transforming growth fac-tor-betal-mediated growth inhibition in COLO-357 cells through functional inactivation of the retinoblastoma protein. J. Biol. Chem., 2005, 280(23), 21858-21866.
94. Liu, X.; Lee, J.; Cooley, M.; Bhogte, E.; Hartley, S.; Glick, A. Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma. Cancer Res., 2003, 65(22), 7760-7768.
95. Leng, A.; Liu, T.; He, Y.; Li, Q.; Zhang, G. Smad4/Smad7 balance: a role of tumorigenesis in gastric cancer. Exp. Mol. Pathol, 2009, 57(1), 48-53.
96. Broderick, P.; Carvajal-Carmona, L.; Pittman, A.M.; Webb, E.; Howarth, K.; Rowan, A.; Lubbe, S.; Spain, S.; Sullivan, K.; Fielding, S.; Jaeger, E.; Vijayakrishnan, J.; Kemp, Z.; Gorman, M.; Chandler, I.; Papaemmanuil, E.; Penegar, S.; Wood, W.; Sellick, G.; Qureshi, M.; Teixeira, A.; Domingo, E.; Barclay, E.; Martin, L.; Sieber, O.; Kerr, D.; Gray, R.; Peto, J.; Cazier, JB.; Tomlinson, I.; Houlston, RS. CORGI Consortium.; A genome-wide association study shows that common alíeles of SMAD7 influence colo-rectal cancer risk. Nat. Genet, 2007, 39(11), 1315-1317.
97. Haider, S.K.; Beauchamp, R.D.; Datta, P.K. Smad7 induces tumorigenicity by blocking TGF-beta-induced growth inhibition and apoptosis. Exp. Cell. Res., 2005, 307(1), 231-246.
98. Haider, S.K.; Rachakonda, G.; Deane, N.G.; Datta, P.K. Smad7 induces hepatic metastasis in colorectal cancer. Br. J. Cancer, 2008, 99(6), 957-965.
99. Azuma, H.; Ehata, S.; Miyazaki, H.; Watabe, T.; Maruyama, O.; Imamura, T.; Sakamoto, T.; Kiyama, S.; Kiyama, Y.; Ubai, T.; In-amoto, T.; Takahara, S.; Itoh, Y.; Otsuki, Y.; Katsuoka, Y.; Miyazono, K.; Horie, S. Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells. J. Nati. Cancer Inst, 2005,97(23), 1734-1746.
100. Wang, P.; Fan, J.; Chen, Z.; Meng, Z.Q.; Luo, J.M.; Lin, J.H.; Zhou, Z.H.; Chen, H.; Wang, K.; Xu, Z.D.; Liu, L.M. Low-Level Expression of Smad7 correlates with lymph node metastasis and poor prognosis in patients with pancreatic cancer. Ann. Surg. On-col., 2009, 16(4), 826-835.
101. Heikkinen, P.T.; Nummela, M.; Jokilehto, T.; Grenman, R.; Kähäri, V.M.; Jaakkola, P.M. Hypoxie conversion of SMAD7 function from an inhibitor into a promoter of cell invasion. Cancer Res., 2010, 70(14), 5984-5993.
102. Nakahata, S.; Yamazaki, S.; Nakauchi, H.; Morishita, K. Down-regulation of ZEB1 and overexpression of Smad7 contribute to resistance to TGF-betal-mediated growth suppression in adult T-cell leukemia/lymphoma. Oncogene, 2010, 29(29), 4157-4169.
103. Smart, N.G.; Apelqvist, A.A.; Gu, X.; Harmon, E.B.; Topper, J.N.; MacDonald, R.J.; Kim, S.K. Conditional expression of Smad7 in pancreatic beta cells disrupts TGF-beta signaling and induces reversible diabetes mellitus. PLoSBiol, 2006, 4(2), e39.
104. Boirivant, M.; Pallone, F.; Di Giacinto, C; Fina, D.; Monteleone, I.; Marinaro, M.; Caruso, R.; Colantoni, A.; Palmieri, G.; Sanchez, M.; Strober, W.; MacDonald, T.T.; Monteleone, G. Inhibition of Smad7 with a specific antisense oligonucleotide facilitates TGF-betal-mediated suppression of colitis. Gastroenterology, 2006, 757(6), 1786-1798.
105. Wang, W.; Huang, X.R.; Li, A.G.; Liu, F.; Li, J.H.; Truong, L.D.; Wang, X.J.; Lan, H.Y. Signaling mechanism of TGF-betal in prevention of renal Inflammation: role of Smad7. J. Am. Soc. Nephrol., 2005, 76(5), 1371-1383.
106. Monteleone, G.; Del Vecchio Blanco, G.; Monteleone, I.; Fina, D.; Caruso, R.; Gioia, V.; Ballerini, S.; Federici, G.; Bernardini, S.; Pallone, F.; MacDonald, T.T. Post-transcriptional regulation of Smad7 in the gut of patients with inflammatory bowel disease. Gastroenterology, 2005, 729(5), 1420-1429.
107. Monteleone, G.; Pallone, F.; MacDonald, T.T. Smad7 in TGF-beta-mediated negative regulation of gut inflammation. Trends Immunol, 2004, 25(10), 513-517.
108. Kleiter, I.; Pedré, X.; Mueller, A.M.; Poeschl, P.; Couillard-Despres, S.; Spruss, T.; Bogdahn, U.; Giegerich, G.; Steinbrecher, A. Inhibition of Smad7, a negative regulator of TGF-beta signaling, suppresses autoimmune encephalomyelitis. J. Neuroimmunol, 2007, 187(1-2), 61-73.
109. Pan, S.; Li, T.; Li, Y. Effects of asiaticoside on cell proliferation and Smad signal pathway of hypertrophie scar fibroblasts. Zhongguo Xiu Fu Chong Man Wai Ke Za Zhi, 2004, 18(4), 291-294.
110. Qi, S.H.; Xie, J.L.; Pan, S.; Xu, Y.B.; Li, T.Z.; Tang, J.M.; Liu, X.S.; Shu, B.; Liu, P. Effects of asiaticoside on the expression of Smad protein by normal skin fibroblasts and hypertrophie scar fibroblasts. Clin. Exp. Dermatol, 2008, 33(2), 171-175.
111. Ju-Lin, X.; Shao-Hai, Q.; Tian-Zeng, L.; Bin, H.; Jing-Ming, T.; Ying-Bin, X.; Xu-Sheng, L.; Bin, S.; Hui-Zhen, L.; Yong, H. Effect of asiaticoside on hypertrophie scar in the rabbit ear model. J. Cutan. Pathol, 2009, 56(2), 234-239.